Hallucinogens

Name
Hallucinogens
Accession Number
DBCAT000908
Description

Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.

Drugs
DrugDrug Description
DronabinolA synthetic delta-9-THC used in the treatment of anorexia and weight loss in HIV patients as well as nausea and vomiting in cancer chemotherapy.
BufotenineA hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a...
MidomafetamineClinical trials are now testing the therapeutic potential of MDMA for post-traumatic stress disorder (PTSD) and anxiety associated with terminal cancer. MDMA is one of the four most widely used...
4-MethoxyamphetamineNot Available
4-Bromo-2,5-dimethoxyamphetamineNot Available
DimethyltryptamineSome people use this compound as a psychedelic inducing agent.
TenamfetamineAn amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons...
PhencyclidineA hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to ketamine in structure and in many of its effects. Like...
Lysergic acid diethylamideDebate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by...
PsilocybinPsilocybin has been investigated for the treatment of Anxiety and Stage IV Melanoma. In November, 2019, it was granted Breakthrough Therapy status by the FDA.
Salvinorin ASalvinorin A has been investigated for the basic science of Pharmaceutical Preparations.
HarmineNot Available
Drugs & Drug Targets
DrugTargetType
DronabinolCannabinoid receptor 1target
DronabinolCytochrome P450 3A4enzyme
DronabinolCytochrome P450 2C9enzyme
DronabinolCannabinoid receptor 2target
DronabinolP-glycoprotein 1transporter
DronabinolATP-binding cassette sub-family G member 2transporter
DronabinolProstaglandin G/H synthase 1enzyme
DronabinolCytochrome P450 2C19enzyme
DronabinolCytochrome P450 1A1enzyme
DronabinolCytochrome P450 1A2enzyme
DronabinolCytochrome P450 1B1enzyme
DronabinolCytochrome P450 2A6enzyme
DronabinolCytochrome P450 2B6enzyme
DronabinolCytochrome P450 2D6enzyme
DronabinolCytochrome P450 2J2enzyme
DronabinolCytochrome P450 3A5enzyme
DronabinolCytochrome P450 3A7enzyme
DronabinolMultidrug resistance-associated protein 1transporter
DronabinolLiver carboxylesterase 1enzyme
DronabinolUDP-glucuronosyltransferase 1-1enzyme
DronabinolUDP-glucuronosyltransferase 1-3enzyme
DronabinolUDP-glucuronosyltransferase 1-9enzyme
DronabinolUDP-glucuronosyltransferase 1-10enzyme
BufotenineAmine oxidase [flavin-containing] Aenzyme
MidomafetamineSodium-dependent serotonin transportertarget
MidomafetamineSynaptic vesicular amine transportertarget
MidomafetamineSodium-dependent dopamine transportertarget
Midomafetamine5-hydroxytryptamine receptor 2Atarget
Midomafetamine5-hydroxytryptamine receptor 2Btarget
Midomafetamine5-hydroxytryptamine receptor 2Ctarget
MidomafetamineSodium-dependent noradrenaline transportertarget
MidomafetamineSodium-dependent noradrenaline transportertransporter
MidomafetamineSodium-dependent dopamine transportertransporter
MidomafetamineSodium-dependent serotonin transportertransporter
MidomafetamineCytochrome P450 2D6enzyme
4-MethoxyamphetamineAlpha-1A adrenergic receptortarget
4-MethoxyamphetamineAlpha-2A adrenergic receptortarget
4-MethoxyamphetamineCytochrome P450 2D6enzyme
4-MethoxyamphetamineSodium-dependent dopamine transportertarget
4-MethoxyamphetamineSodium-dependent serotonin transportertarget
4-MethoxyamphetamineAmine oxidase [flavin-containing] Atarget
4-MethoxyamphetamineAmine oxidase [flavin-containing] Btarget
4-MethoxyamphetamineSynaptic vesicular amine transportertarget
Dimethyltryptamine5-hydroxytryptamine receptor 6target
Dimethyltryptamine5-hydroxytryptamine receptor 2Atarget
DimethyltryptamineSigma non-opioid intracellular receptor 1target
PhencyclidineGlutamate receptor ionotropic, NMDA 3Atarget
PhencyclidineSigma non-opioid intracellular receptor 1target
PhencyclidineCytochrome P450 2B6enzyme
Lysergic acid diethylamide5-hydroxytryptamine receptor 1Atarget
Lysergic acid diethylamide5-hydroxytryptamine receptor 2Btarget
Lysergic acid diethylamide5-hydroxytryptamine receptor 6target
Lysergic acid diethylamideCytochrome P450 3A4enzyme
Lysergic acid diethylamideCytochrome P450 2D6enzyme
HarmineAmine oxidase [flavin-containing] Atarget